As noted above, this may be particularly true of the peptides gastroprotective effects [9, 31]
When you're studying a synergistic effect, the need for purity is magnified
Side effects are rare, but some individuals may experience mild pain at the injection site, allergic reactions, or dizziness
The injectable form delivers compound directly into the bloodstream for systemic distribution throughout the body
Safety Considerations and UK Regulatory Status Retatrutide is not MHRA-approved, meaning self-use outside clinical trials carries risks including product impurity, incorrect dosing, gastrointestinal adverse effects, and no pharmacovigilance oversight
Across 174+ conditions